Nerivio Efficacy by Time of Treatment Onset

PHASE4CompletedINTERVENTIONAL
Enrollment

55,261

Participants

Timeline

Start Date

May 7, 2025

Primary Completion Date

June 10, 2025

Study Completion Date

June 15, 2025

Conditions
MigraineAcute Treatment of Migraine
Interventions
DEVICE

Nerivio

Remote electrical neuromodulation (REN) device for the acute treatment of migraines. The device delivers transcutaneous electrical stimulation to the upper arm to induce conditioned pain modulation (CPM) that activates a descending endogenous analgesic mechanism. The treatment is self-administered and controlled by a smartphone application

Trial Locations (1)

08807

Theranica Bio-Electronics Inc, Bridgewater

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Theranica

INDUSTRY

NCT06976723 - Nerivio Efficacy by Time of Treatment Onset | Biotech Hunter | Biotech Hunter